Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1988 Jul;149(1):47–57.

Modern Neurosyphilis—A Critical Analysis

Kenneth G Jordan
PMCID: PMC1026245  PMID: 3043897

Abstract

Neurosyphilis remains a source of perplexity for today's physicians. Controversies exist over the interpretation of serologic tests, cerebrospinal fluid (CSF) abnormalities, diagnostic criteria, and treatment regimens. Its occurrence with human immunodeficiency virus (HIV) infection has raised fears of its recrudescence. A critical analysis of the evidence behind these viewpoints leads to several conclusions: the CSF VDRL is the most appropriate diagnostic test; pleocytosis is the only reliable CSF measure of disease activity; commonly accepted diagnostic criteria do not exclude nonsyphilitic disease; and treatment requires the prolonged use of parenteral penicillin, but no superior regimen has been found. Most data do not currently support the view that concurrent HIV infection produces accelerated or resistant neurosyphilis.

Full text

PDF
47

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayne L. L., Schmidley J. W., Goodin D. S. Acute syphilitic meningitis. Its occurrence after clinical and serologic cure of secondary syphilis with penicillin G. Arch Neurol. 1986 Feb;43(2):137–138. doi: 10.1001/archneur.1986.00520020031012. [DOI] [PubMed] [Google Scholar]
  2. Berry C. D., Hooton T. M., Collier A. C., Lukehart S. A. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med. 1987 Jun 18;316(25):1587–1589. doi: 10.1056/NEJM198706183162507. [DOI] [PubMed] [Google Scholar]
  3. Birry A., Kasatiya S. Evaluation of microhaemagglutination assay to determine treponemal antibodies in CSF. Br J Vener Dis. 1979 Aug;55(4):239–244. doi: 10.1136/sti.55.4.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bracero L., Wormser G. P., Bottone E. J. Serologic tests for syphilis: a guide to interpretation in various stages of disease. Mt Sinai J Med. 1979 May-Jun;46(3):289–292. [PubMed] [Google Scholar]
  5. Burke J. M., Schaberg D. R. Neurosyphilis in the antibiotic era. Neurology. 1985 Sep;35(9):1368–1371. doi: 10.1212/wnl.35.9.1368. [DOI] [PubMed] [Google Scholar]
  6. CLARK E. G., DANBOLT N. The Oslo study of the natural history of untreated syphilis; an epidemiologic investigation based on a restudy of the Boeck-Bruusgaard material; a review and appraisal. J Chronic Dis. 1955 Sep;2(3):311–344. doi: 10.1016/0021-9681(55)90139-9. [DOI] [PubMed] [Google Scholar]
  7. COLLART P., BOREL L. J., DUREL P. SIGNIFICANCE OF SPIRAL ORGANISMS FOUND, AFTER TREATMENT, IN LATE HUMAN AND EXPERIMENTAL SYPHILIS. Br J Vener Dis. 1964 Jun;40:81–89. doi: 10.1136/sti.40.2.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CURTIS A. C., CUTLER J. C., GAMMON G., GLEESON G. A., HAHN R. D., HEYMAN A., JOHNWICK E., SOLOMON H., STOKES J. H., THOMAS E. Penicillin treatment of asymptomatic central nervous system syphilis. I. Probability of progression to symptomatic neurosyphilis. AMA Arch Derm. 1956 Oct;74(4):355–366. doi: 10.1001/archderm.1956.01550100023006. [DOI] [PubMed] [Google Scholar]
  9. Cassens B. J. Social consequences of the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov;103(5):768–771. doi: 10.7326/0003-4819-103-5-768. [DOI] [PubMed] [Google Scholar]
  10. Catterall R. D. Neurosyphilis. Br J Hosp Med. 1977 Jun;17(6):585–604. [PubMed] [Google Scholar]
  11. Cave V. G., Nikitas J. A. Venereal disease--clinical and laboratory diagnoses. Mt Sinai J Med. 1976 Nov-Dec;43(6):795–829. [PubMed] [Google Scholar]
  12. DATTNER B., THOMAS E. W., DE MELLO L. Criteria for the management of neurosyphilis. Am J Med. 1951 Apr;10(4):463–467. doi: 10.1016/0002-9343(51)90292-6. [DOI] [PubMed] [Google Scholar]
  13. Dalakas M. C. Chronic idiopathic ataxic neuropathy. Ann Neurol. 1986 Jun;19(6):545–554. doi: 10.1002/ana.410190605. [DOI] [PubMed] [Google Scholar]
  14. Dans P. E., Cafferty L., Otter S. E., Johnson R. J. Inappropriate use of the cerebrospinal fluid Venereal Disease Research Laboratory (VDRL) test to exclude neurosyphilis. Ann Intern Med. 1986 Jan;104(1):86–89. doi: 10.7326/0003-4819-104-1-86. [DOI] [PubMed] [Google Scholar]
  15. Dans P. E. Treatment of Gonorrhea and syphilis: Part II--syphilis. South Med J. 1975 Oct;68(10):1295–1303. doi: 10.1097/00007611-197510000-00028. [DOI] [PubMed] [Google Scholar]
  16. Davis L. E., Sperry S. Bell's palsy and secondary syphilis: CSF spirochetes detected by immunofluorescence. Ann Neurol. 1978 Oct;4(4):378–380. doi: 10.1002/ana.410040416. [DOI] [PubMed] [Google Scholar]
  17. Davis L. E., Sperry S. The CSF-FTA test and the significance of blood contamination. Ann Neurol. 1979 Jul;6(1):68–69. doi: 10.1002/ana.410060116. [DOI] [PubMed] [Google Scholar]
  18. Dawson-Butterworth K., Heathcote P. R. Review of hospitalized cases of general paralysis of the insane. Br J Vener Dis. 1970 Aug;46(4):295–302. doi: 10.1136/sti.46.4.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dewhurst K. Treatment of the neurosyphilitic psychoses. Acta Psychiatr Scand. 1969;45(1):62–74. doi: 10.1111/j.1600-0447.1969.tb06202.x. [DOI] [PubMed] [Google Scholar]
  20. Diagnostic criteria for neurosyphilis. Neurology. 1986 Sep;36(9):1273–1274. [PubMed] [Google Scholar]
  21. Ducas J., Robson H. G. Cerebrospinal fluid penicillin levels during therapy for latent syphilis. JAMA. 1981 Dec 4;246(22):2583–2584. [PubMed] [Google Scholar]
  22. Duncan W. P., Jenkins T. W., Parham C. E. Fluorescent treponemal antibody-cerebrospinal fluid (FTA-CSF) test. A provisional technique. Br J Vener Dis. 1972 Apr;48(2):97–101. doi: 10.1136/sti.48.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Duncan W. P., Kuhn U. S., 3rd Reactivity of treponemal and nontreponemal tests with cerebrospinal fluid from syphilitic chimpanzees. J Infect Dis. 1972 Jan;125(1):61–65. doi: 10.1093/infdis/125.1.61. [DOI] [PubMed] [Google Scholar]
  24. Dunlop E. M., Al-Egaily S. S., Houang E. T. Penicillin levels in blood and CSF achieved by treatment of syphilis. JAMA. 1979 Jun 8;241(23):2538–2540. [PubMed] [Google Scholar]
  25. Dunlop E. M. Persistence of treponemes after treatment. Br Med J. 1972 Jun 3;2(5813):577–580. doi: 10.1136/bmj.2.5813.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Fernando W. L. Cerebrospinal fluid findings after treatment of early syphilis with penicillin. Br J Vener Dis. 1965 Sep;41(3):168–169. doi: 10.1136/sti.41.3.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Fernando W. L. Cerebrospinal fluid findings after treatment of early syphilis with penicillin. Br J Vener Dis. 1965 Sep;41(3):168–169. doi: 10.1136/sti.41.3.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Fitzgerald T. J., Johnson R. C., Sykes J. A., Miller J. N. Interaction of Treponema pallidum (Nichols strain) with cultured mammalian cells: effects of oxygen, reducing agents, serum supplements, and different cell types. Infect Immun. 1977 Feb;15(2):444–452. doi: 10.1128/iai.15.2.444-452.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Fiumara N. J. Treatment of primary and secondary syphilis. Serological response. JAMA. 1980 Jun 27;243(24):2500–2502. [PubMed] [Google Scholar]
  30. Gager W. E., Israel C. W., Smith J. L. Presence of spirochaetes in paresis despite penicillin therapy. Br J Vener Dis. 1968 Dec;44(4):277–282. doi: 10.1136/sti.44.4.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Gelfand J. A., Elin R. J., Berry F. W., Jr, Frank M. M. Endotoxemia associated with the Jarisch-Herxheimer reaction. N Engl J Med. 1976 Jul 22;295(4):211–213. doi: 10.1056/NEJM197607222950409. [DOI] [PubMed] [Google Scholar]
  32. Greene B. M., Miller N. R., Bynum T. E. Failure of penicillin G benzathine in the treatment of neurosyphilis. Arch Intern Med. 1980 Aug;140(8):1117–1118. [PubMed] [Google Scholar]
  33. HARRIS A., BOSSAK H. M., DEACON W. E., BUNCH W. L., Jr Comparison of the fluorescent treponemal antibody test with other tests for syphilis on cerebrospinal fluids. Br J Vener Dis. 1960 Sep;36:178–180. doi: 10.1136/sti.36.3.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med. 1986 Mar;104(3):368–376. doi: 10.7326/0003-4819-104-3-368. [DOI] [PubMed] [Google Scholar]
  35. Heathfield K. W. The decline of neurolues. Practitioner. 1976 Nov;217(1301):753–762. [PubMed] [Google Scholar]
  36. Hicks C. B., Benson P. M., Lupton G. P., Tramont E. C. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. A diagnostic dilemma. Ann Intern Med. 1987 Oct;107(4):492–495. doi: 10.7326/0003-4819-107-4-492. [DOI] [PubMed] [Google Scholar]
  37. Hooshmand H., Escobar M. R., Kopf S. W. Neurosyphilis. A study of 241 patients. JAMA. 1972 Feb;219(6):726–729. doi: 10.1001/jama.219.6.726. [DOI] [PubMed] [Google Scholar]
  38. Hotson J. R. Modern neurosyphilis: a partially treated chronic meningitis. West J Med. 1981 Sep;135(3):191–200. [PMC free article] [PubMed] [Google Scholar]
  39. Idsoe O., Guthe T., Willcox R. R. Penicillin in the treatment of syphilis. The experience of three decades. Bull World Health Organ. 1972;47 (Suppl):1–68. [PMC free article] [PubMed] [Google Scholar]
  40. Jaffe H. W., Larsen S. A., Peters M., Jove D. F., Lopez B., Schroeter A. L. Tests for treponemal antibody in CSF. Arch Intern Med. 1978 Feb;138(2):252–255. [PubMed] [Google Scholar]
  41. Jaffe H. W. The laboratory diagnosis of syphilis. New concepts. Ann Intern Med. 1975 Dec;83(6):846–850. doi: 10.7326/0003-4819-83-6-846. [DOI] [PubMed] [Google Scholar]
  42. Joffe R., Black M. M., Floyd M. Changing clinical picture of neurosyphilis: report of seven unusual cases. Br Med J. 1968 Jan 27;1(5586):211–212. doi: 10.1136/bmj.1.5586.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Johns D. R., Tierney M., Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med. 1987 Jun 18;316(25):1569–1572. doi: 10.1056/NEJM198706183162503. [DOI] [PubMed] [Google Scholar]
  44. Jordan K. More on neurosyphilis. West J Med. 1982 Feb;136(2):166–167. [PMC free article] [PubMed] [Google Scholar]
  45. Joyce-Clarke N., Molteno A. C. Modified neurosyphilis in the Cape Peninsula. S Afr Med J. 1978 Jan 7;53(1):10–14. [PubMed] [Google Scholar]
  46. Kabat E. A., Moore D. H., Landow H. AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS. J Clin Invest. 1942 Sep;21(5):571–577. doi: 10.1172/JCI101335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Kampmeier R. H. Establishment of Treponema pallidum as the etiologic agent in general paralysis. Sex Transm Dis. 1980 Oct-Dec;7(4):197–198. doi: 10.1097/00007435-198010000-00013. [DOI] [PubMed] [Google Scholar]
  48. Kampmeier R. H., Sweeney A., Quinn R. W., Lefkowitz L. B., Dupont W. D. A survey of 251 patients with acute syphilis treated in the collaborative penicillin study of 1943-1950. Sex Transm Dis. 1981 Oct-Dec;8(4):266–279. doi: 10.1097/00007435-198110000-00006. [DOI] [PubMed] [Google Scholar]
  49. Kampmeier R. H. Whatever has happened to locomotor ataxy. J Am Vener Dis Assoc. 1976 Dec;3(2 Pt 1):51–53. [PubMed] [Google Scholar]
  50. Kolar O. J., Burkhart J. E. Neurosyphilis. Br J Vener Dis. 1977 Aug;53(4):221–225. doi: 10.1136/sti.53.4.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Levy R. M., Bredesen D. E., Rosenblum M. L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985 Apr;62(4):475–495. doi: 10.3171/jns.1985.62.4.0475. [DOI] [PubMed] [Google Scholar]
  52. Luger A., Schmidt B. L., Steyrer K., Schonwald E. Diagnosis of neurosyphilis by examination of the cerebrospinal fluid. Br J Vener Dis. 1981 Aug;57(4):232–237. doi: 10.1136/sti.57.4.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Luger A., Schmidt B., Spendlingwimmer I. Quantitative evaluation of the FTA-ABS-IgM and VDRL test in treated and untreated syphilis. Br J Vener Dis. 1977 Oct;53(5):287–291. doi: 10.1136/sti.53.5.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Luxon L., Lees A. J., Greenwood R. J. Neurosyphilis today. Lancet. 1979 Jan;1(8107):90–93. doi: 10.1016/s0140-6736(79)90074-6. [DOI] [PubMed] [Google Scholar]
  55. Madiedo G., Ho K. C., Walsh P. False-positive VDRL and FTA in cerebrospinal fluid. JAMA. 1980 Aug 15;244(7):688–689. [PubMed] [Google Scholar]
  56. Mahony J. D., Harris J. R., McCann J. S., Kennedy J., Dougan H. J. Evaluation of the C.S.F. F.T.A. ABS test in latent and tertiary treated syphilis. Acta Derm Venereol. 1972;52(1):71–74. [PubMed] [Google Scholar]
  57. Martin J. P. Conquest of general paralysis. Br Med J. 1972 Jul 15;3(5819):159–160. doi: 10.1136/bmj.3.5819.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Mazzarello P., Poloni M., Citterio A., Camana C., Ceroni M. Cerebrospinal fluid IgG changes in neurosyphilis after high-dose penicillin G treatment. Arch Neurol. 1987 Mar;44(3):249–249. doi: 10.1001/archneur.1987.00520150005003. [DOI] [PubMed] [Google Scholar]
  59. Miller J. N. Value and limitations of nontreponemal and treponemal tests in the laboratory diagnosis of syphilis. Clin Obstet Gynecol. 1975 Mar;18(1):191–203. doi: 10.1097/00003081-197503000-00017. [DOI] [PubMed] [Google Scholar]
  60. Mohr J. A., Griffiths W., Jackson R., Saadah H., Bird P., Riddle J. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA. 1976 Nov 8;236(19):2208–2209. [PubMed] [Google Scholar]
  61. Moskovitz B. L., Klimek J. J., Goldman R. L., Fiumara N. J., Quintiliani R. Meningovascular syphilis after 'appropriate' treatment of primary syphilis. Arch Intern Med. 1982 Jan;142(1):139–140. [PubMed] [Google Scholar]
  62. Musher D. M., Schell R. F., Knox J. M. The immunology of syphilis. Int J Dermatol. 1976 Oct;15(8):566–576. doi: 10.1111/j.1365-4362.1976.tb04891.x. [DOI] [PubMed] [Google Scholar]
  63. Müller F., Lindenschmidt E. G. Demonstration of specific 19S(IgM) antibodies in untreated and treated syphilis. Comparative studies of the 19S(IgM)-FTA test, the 19S(IgM)-TPHA test, and the solid phase haemadsorption assay. Br J Vener Dis. 1982 Feb;58(1):12–17. doi: 10.1136/sti.58.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Müller F., Moskophidis M. Estimation of the local production of antibodies to Treponema pallidum in the central nervous system of patients with neurosyphilis. Br J Vener Dis. 1983 Apr;59(2):80–84. doi: 10.1136/sti.59.2.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Neurosyphilis and HIV infection. N Engl J Med. 1987 Dec 3;317(23):1473–1475. doi: 10.1056/NEJM198712033172310. [DOI] [PubMed] [Google Scholar]
  66. Nichols S. E. Psychosocial reactions of persons with the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov;103(5):765–767. doi: 10.7326/0003-4819-103-5-765. [DOI] [PubMed] [Google Scholar]
  67. Panconesi E., Zuccati G., Cantini A. Treatment of syphilis: a short critical review. Sex Transm Dis. 1981 Oct-Dec;8(4 Suppl):321–325. [PubMed] [Google Scholar]
  68. Pirozzi D. J. Editorial: Syphillis and penicillin. Ann Intern Med. 1973 Sep;79(3):447–449. doi: 10.7326/0003-4819-79-3-447. [DOI] [PubMed] [Google Scholar]
  69. Polnikorn N., Witoonpanich R., Vorachit M., Vejjajiva S., Vejjajiva A. Penicillin concentrations in cerebrospinal fluid after different treatment regimens for syphilis. Br J Vener Dis. 1980 Dec;56(6):363–367. doi: 10.1136/sti.56.6.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Rein M. F. Treatment of neurosyphilis. JAMA. 1981 Dec 4;246(22):2613–2614. [PubMed] [Google Scholar]
  71. Rice N. S., Dunlop E. M., Jones B. R., Hare M. J., King A. J., Rodin P., Mushin A., Wilkinson A. E. Demonstration of treponeme-like forms in cases of treated and untreated late syphilis and of treated early syphilis. Br J Vener Dis. 1970 Feb;46(1):1–9. doi: 10.1136/sti.46.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Rothenberg R. Treatment of neurosyphilis. J Am Vener Dis Assoc. 1976 Dec;3(2 Pt 2):153–158. [PubMed] [Google Scholar]
  73. Schoth P. E., Wolters E. C. Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilis. Neurology. 1987 Jul;37(7):1214–1216. doi: 10.1212/wnl.37.7.1214. [DOI] [PubMed] [Google Scholar]
  74. Simon R. P. Neurosyphilis. Arch Neurol. 1985 Jun;42(6):606–613. doi: 10.1001/archneur.1985.04060060112021. [DOI] [PubMed] [Google Scholar]
  75. Snider W. D., Simpson D. M., Nielsen S., Gold J. W., Metroka C. E., Posner J. B. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983 Oct;14(4):403–418. doi: 10.1002/ana.410140404. [DOI] [PubMed] [Google Scholar]
  76. Tramont E. C. Persistence of Treponema pallidum following penicillin G therapy. Report of two cases. JAMA. 1976 Nov 8;236(19):2206–2207. [PubMed] [Google Scholar]
  77. Tramont E. C. Syphilis in the AIDS era. N Engl J Med. 1987 Jun 18;316(25):1600–1601. doi: 10.1056/NEJM198706183162510. [DOI] [PubMed] [Google Scholar]
  78. Traviesa D. C., Prystowsky S. D., Nelson B. J., Johnson K. P. Cerebrospinal fluid findings in asymptomatic patients with reactive serum fluorescent treponemal antibody absorption tests. Ann Neurol. 1978 Dec;4(6):524–530. doi: 10.1002/ana.410040608. [DOI] [PubMed] [Google Scholar]
  79. Turner T. B., Hardy P. H., Newman B. Infectivity tests in syphilis. Br J Vener Dis. 1969 Sep;45(3):183–195. doi: 10.1136/sti.45.3.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Vartdal F., Vandvik B., Michaelsen T. E., Loe K., Norrby E. Neurosyphilis: intrathecal synthesis of oligoclonal antibodies to Treponema pallidum. Ann Neurol. 1982 Jan;11(1):35–40. doi: 10.1002/ana.410110107. [DOI] [PubMed] [Google Scholar]
  81. Venkoba Rao A., Ranganathan P. S., Natarajan M. Report on a study of cerebral biopsy in general paretics. Neurol India. 1969 Jan-Mar;17(1):26–27. [PubMed] [Google Scholar]
  82. Wiesel J., Rose D. N., Silver A. L., Sacks H. S., Bernstein R. H. Lumbar puncture in asymptomatic late syphilis. An analysis of the benefits and risks. Arch Intern Med. 1985 Mar;145(3):465–468. [PubMed] [Google Scholar]
  83. Wilner E., Brody J. A. Prognosis of general paresis after treatment. Lancet. 1968 Dec 28;2(7583):1370–1371. doi: 10.1016/s0140-6736(68)92674-3. [DOI] [PubMed] [Google Scholar]
  84. Yobs A. R., Clark J. W., Jr, Mothershed S. E., Bullard J. C., Artley C. W. Further observations on the persistence of Treponema pallidum after treatment in rabbits and humans. Br J Vener Dis. 1968 Jun;44(2):116–130. doi: 10.1136/sti.44.2.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Yoder F. W. Penicillin treatment of neurosyphilis. Are recommended dosages sufficient? JAMA. 1975 Apr 21;232(3):270–271. [PubMed] [Google Scholar]
  86. Yoder F. W. Penicillin treatment of neurosyphilis. Are recommended dosages sufficient? JAMA. 1975 Apr 21;232(3):270–271. [PubMed] [Google Scholar]
  87. van Eijk R. V., Wolters E. C., Tutuarima J. A., Hische E. A., Bos J. D., van Trotsenburg L., de Koning G. A., van der Helm H. J. Effect of early and late syphilis on central nervous system: cerebrospinal fluid changes and neurological deficit. Genitourin Med. 1987 Apr;63(2):77–82. doi: 10.1136/sti.63.2.77. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES